| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 22,225,000 | 18,100,000 | 18,364,000 | 16,954,000 | | Cost of Revenue | 17,128,000 | 15,936,000 | 20,371,000 | 13,143,000 | | | Gross Profit | 5,097,000 | 2,164,000 | (2,007,000) | 3,811,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,999,000 | 423,000 | (3,371,000) | 1,783,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 504,000 | 451,000 | 415,000 | 409,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,594,000 | 1,290,000 | 949,000 | 1,619,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (9,000) | 9,000 | 42,000 | 125,000 | | Earnings Before Interest And Taxes | 1,585,000 | 1,299,000 | 991,000 | 1,747,000 | | Interest Expense | 1,000 |
-
|
-
|
-
| | Income Before Tax | 1,584,000 | 1,299,000 | 991,000 | 1,747,000 | | Income Tax Expense | 810,000 | 568,000 | 323,000 | 726,000 | | Minority Interest |
-
|
-
|
-
| 3,000 | | | | Net Income From Continuing Ops | 774,000 | 731,000 | 668,000 | 1,021,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 774,000 | 731,000 | 668,000 | 1,021,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $774,000 | $731,000 | $668,000 | $1,021,000 |
|
1.49% Nasdaq 
0.27%
Income Statement
